NPPB and hydrops fetalis: This prospective single-center study conducted at KCMH, focusing on patients admitted for AHF syndrome regardless of ejection fraction, revealed that lower levels of GDF-15 and NT-proBNP served as valuable biomarkers for assessing the risk of HF readmission and all-cause mortality.